IMT Header

Cambridge Healthtech Institute’s 10th Annual
Novel Vaccines
Part One: Adjuvants
August 24-25


Many recently developed vaccines are comprised of recombinant molecules or subunits of pathogenic organisms, requiring formulation with adjuvants to increase and direct the immune response. The benefit of adjuvants is clear: they may reduce the amount of antigen and number of vaccinations needed, accelerate the immune response, increase cross-protection, and improve efficacy in populations that are poor responders. As we continue to confront emerging and re-emerging disease threats and progress toward developing new vaccines to improve global health, there is also an urgent need for the development of novel adjuvants. CHI’s Tenth Annual Novel Vaccines: Adjuvants meeting will cover the latest advances in a range of adjuvants, from archaeosomes to TLRs, present case studies of successful formulations against challenging diseases, and address issues related to regulatory approval and understanding mode of action.

The meeting will cover a range of topics, including: 

  • Regulatory considerations and challenges
  • Modes of action and safety issues
  • Advances in combination adjuvants
  • Adjuvants for mucosal vaccines
  • Archaeosomes and other novel lipid-based adjuvants
  • DNA- and RNA-based adjuvants
  • Toll-like receptors
  • Rational design and optimization

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract.  Remember to specify the conference that you are interested in and please provide your full contact information.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality conference program.  

If you are interested in presenting, please submit a speaking proposal for review.  Replies to proposals can take up to 8-12 weeks. We will notify you once the agenda has been finalized.

Deadline for submission is February 2, 2015. 

We welcome your comments, suggestions and speaker suggestions as we shape the 2015 program

For more details on the conference, please contact:
Virginia Maxwell
Associate Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5436
E: vmaxwell@healthtech.com  

For exhibit & sponsorship opportunities, please contact:
Katelin Fitzgerald
Sr. Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5458
E: kfitzgerald@healthtech.com